Insulin Analog [EPC]

356101 reported adverse events

Drugs of this class: INSULIN ASPART INSULIN LISPRO INSULIN GLARGINE INSULIN DETEMIR INSULIN GLARGINE-YFGN (INSULIN DEGLUDEC AND LIRAGLUTIDE) ATTENTION DEFICIT MILD DROPS ATTENTION DEFICIT SEVERE DROPS DNA INSULIN DROPS INSULIN INSULIN ASPART INJECTION

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

#	Side effect	Count
0	BLOOD GLUCOSE INCREASED	65532
1	DRUG INEFFECTIVE	17363
2	BLOOD GLUCOSE DECREASED	16702
3	NAUSEA	15042
4	HYPOGLYCAEMIA	11617
5	FATIGUE	10666
6	MALAISE	10591
7	DIARRHOEA	10444
8	DYSPNOEA	10438
9	VISUAL IMPAIRMENT	10197

See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	DEVICE OPERATIONAL ISSUE	1983	0.8406
1	HYPOGLYCAEMIA UNAWARENESS	229	0.7156
2	HYPOGLYCAEMIC UNCONSCIOUSNESS	1162	0.6670
3	HYPOGLYCAEMIC SEIZURE	414	0.5342
4	DIABETIC RETINOPATHY	1336	0.5152
5	SHOCK HYPOGLYCAEMIC	205	0.5049
6	INTERCEPTED PRODUCT SELECTION ERROR	272	0.4936
7	BLOOD GLUCOSE FLUCTUATION	3976	0.4580
8	INSULIN RESISTANCE	650	0.4449
9	BLOOD GLUCOSE INCREASED	65532	0.4383

See all enriched reactions for Insulin Analog [EPC]